İpucu modu açıktır Kapat

SURI - Simplify Propel Opportunities ETF (USD) (US82889N6242)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
US82889N6242
SURI ISIN
Borsa Yatırım Fonları (BYF)
Fon türü
Simplify Asset Management
Sağlayıcı
-
Hisse başına net varlık değeri
07.02.2023
Başlangıç ​​tarihi
4 yılda ... kez
Temettü ödemeleri
CEOJLS
CFI
SURI
Menkul değer sembolü
Formed
Status
Equity
Yatırım kategorisi
Healthcare
Sektör
Global
Coğrafya
No benchmark
Karşılaştırma ölçütü (benchmark)
2.54 %
Toplam Maliyet Oranı
Physical
Replikasyon yöntemi
76,71 milyon USD
Fonun toplam varlıkları | 20.07.2026
76,71 milyon USD
Hisse senedi sınıfı varlıkları | 20.07.2026
Hayır
UCITS

Getiri on 20.07.2026, NYSE Arca

  • YTD
    8,97 %
  • 1M
    1,21 %
  • 3M
    10,28 %
  • 6M
    13,52 %
  • 1Y
    42,77 %
  • 3Y
    20,88 %
  • 5Y
    -
  • 10Y
    -
Gelir ödemeleri dikkate alınarak borsadaki fiyat üzerinden

Şu tarihe ilişkin son veriler
Karşılaştırmak için öğe ekleyin

Kotasyonlar (SURI)

En kapsamlı veri tabanını keşfedin

1 000 000

tahvi̇ller

100 000

hisse senetleri

175 910

ETF & Funds

100 000

endeksler

Portföyünüzü en etkili şekilde takip edin

  • Tahvi̇l arama
  • Watchlist
  • Excel Eklentisi

Fiyat dinamiklerindeki değişimler

Fund profile

The Simplify Propel Opportunities ETF is an actively managed ETF that seeks long-term capital appreciation by investing in a portfolio comprised primarily of global biotech, pharma, health care technology, and life science companies

SURI profile

The Simplify Propel Opportunities ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The Simplify Asset Management fund’s base currency is USD and the share class was registered 07.02.2023 with unique ISIN - US82889N6242. Main exchange is NYSE Arca and ticker symbol is SURI. The total expense ratio is 2.54%. The Simplify Propel Opportunities ETF (USD) pays dividends 4 time(s) per year.

Yapı SURI on 17.07.2026

Menkul kıymet Değer
PLAINS GP HLDGS L P 42,32%
ACHIEVE LIFE SCIENCES INC USD 0.001 11,66%
MILESTONE PHARMACEUTICALS INC NPV 5,15%
DELCATH SYS INC USD 0.01 4,34%
ACHIEVE LIFE SCIENCES I WTS 30JUN30 4,11%
PHATHOM PHARMACEUTICALS USD 0.0001 3,54%
CORCEPT THERAPEUTICS INC USD 0.001 3,11%
ABEONA THERAPEUTICS INC USD 0.01 2,51%
CELLDEX THERAPEUTICS INC USD 0.001 2,44%
Cash 2,01%
INVENTIVA SA NPV ADR 1,88%
COMPASS PATHWAYS PLC USD 0.008 ADR 1,83%
KYVERNA THERAPEUTICS IN USD 0.00001 1,77%
AQUESTIVE THERAPEUTICS IN USD 0.001 1,49%
LEONABIO INC USD 0.0001 1,4%
ARTIVA BIOTHERAPEUTICS I USD 0.0001 1,28%
Telesat, 5.625% 6dec2026, USD 1,17%
ZEVRA THERAPEUTICS INC USD 0.0001 1,12%
PALISADE BIO INC USD 0.01 1,11%
ORCHESTRA BIOMED HLDGS I USD 0.0001 1,05%
OCULAR THERAPEUTIX INC USD 0.0001 0,94%
ACHIEVE LIFE SCIENCES WTS 0,89%
EYEPOINT INC 0,67%
IMMUNIC INC USD 0.0001 0,6%
UPSTREAM BIO INC USD 0.001 0,57%
AKERO THERAPEUTICS INC CVR 0,55%
SAB BIOTHERAPEUTICS INC USD 0.0001 0,48%
Chinook Therapeutics, ord. 0%
EIGER BIOPHARMACEUTICALS USD 0.0001 0%
WTS - MILESTONE PHARMACEUTICALS INC SERIES B 0%
JASPER THERAPEUTIC WTS 0%
WTS - TENAYA THERAPEUTICS INC 0%
WTS - QUOIN PHARMACEUTICALS LTD - Series K 0%
ALTIMMUNE INC 0%
WTS - QUOIN PHARMACEUTICALS LTD - Series H 0%
WTS - QUOIN PHARMACEUTICALS LTD - Series J 0%
WTS - QUOIN PHARMACEUTICALS LTD - Series I 0%
Other - %

Bu sağlayıcıdan diğer ETF ve Fonlar

Benzer ETF ve Fonlar

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} milyon
    Net Varlık Değeri
    {{ item.expense_ratio }}
    Toplam Maliyet Oranı
Kayıt gereklidir erişim için